ChIP-seq. analysis of pan-histone 3 acetylation in Romidepsin treated TCam-2
Ontology highlight
ABSTRACT: ChIP-seq. analysis of TCam-2 16 h after 10 nanomolar Romidepsin application. DMSO treated cells were used as controls. For ChIP, an antibody against histone H3 pan-acetylation was used. These data are part of the article 'The Histone Deacetylase Inhibitor Romidepsin Efficiently Targets Cisplatin-resistant Germ Cell Cancer Cells via Downregulation of the SWI/SNF-Complex Member ARID1A' (Nettersheim et al., 2016).
ORGANISM(S): Homo sapiens
PROVIDER: GSE78262 | GEO | 2016/09/01
SECONDARY ACCESSION(S): PRJNA313057
REPOSITORIES: GEO
ACCESS DATA